-
TAKEDA PHARMACEUTICALS AMERICA, INC. et al v. APOTEX, INC. DC
- 2:21-cv-12998
- D.N.J.
- Judge: Kevin McNulty
+1
- Filed: 06/25/2021
- Closed: 02/08/2023
- Latest Docket Entry: 02/08/2023
- PACER
3
Plaintiffs
1
Defendant
1
Accused
Product
3
Patents-in-Suit
594
Days in
Litigation
-
TAKEDA PHARMACEUTICALS AMERICA, INC. et al v. APOTEX, INC. DC
- 2:21-cv-12998
- D.N.J.
- Judge: Kevin McNulty
+1
- Filed: 06/25/2021
- Closed: 02/08/2023
- Latest Docket Entry: 02/08/2023
- PACER
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Apotex Inc.
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Crystalline Forms Of Ponatinib Hydrochloride | US 11,192,895 B2 | All Asserted Claims |
Infringement
Entry 127
|
| Crystalline Forms Of Ponatinib Hydrochloride | US 11,192,897 B2 | All Asserted Claims |
Infringement
Entry 127
|
| Crystalline Forms Of Ponatinib Hydrochloride | US 9,493,470 B2 | All Asserted Claims |
Infringement
Entry 127
|
